Geneos Wealth Management’s Innovator US Equity Ultra Buffer ETF October UOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-130
Closed -$3K 3002
2020
Q3
$3K Sell
130
-212
-62% -$5.42K ﹤0.01% 2346
2020
Q2
$8K Sell
342
-200
-37% -$4.86K ﹤0.01% 2012
2020
Q1
$12K Hold
542
﹤0.01% 1745
2019
Q4
$13K Hold
542
﹤0.01% 1881
2019
Q3
$13K Sell
542
-3,500
-87% -$86.9K ﹤0.01% 1796
2019
Q2
$100K Sell
4,042
-100
-2% -$2.45K 0.01% 914
2019
Q1
$100K Buy
4,142
+2,830
+216% +$67.2K 0.01% 862
2018
Q4
$30K Buy
+1,312
New +$31.2K ﹤0.01% 1335

Other funds holding UOCT

Geneos Wealth Management's UOCT Position: Q4 2020 in Review

Geneos Wealth Management sold out of Innovator US Equity Ultra Buffer ETF October (UOCT) in Q4 2020, closing a stake of 130 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in UOCT in Q4 2018 and held it in 8 quarters. The position peaked at $100K in Q2 2019. 34 funds tracked by Wall St. Rank hold UOCT as of Q4 2020.

  • Geneos Wealth Management reported no remaining Innovator US Equity Ultra Buffer ETF October position as of Q4 2020 after selling out during the quarter.
  • Geneos Wealth Management sold 130 Innovator US Equity Ultra Buffer ETF October shares in Q4 2020, an estimated $3K.
  • Geneos Wealth Management first reported a position in Innovator US Equity Ultra Buffer ETF October in Q4 2018 and held it in 8 quarters.
  • Geneos Wealth Management's Innovator US Equity Ultra Buffer ETF October position peaked at $100K in Q2 2019.
  • 34 funds tracked by Wall St. Rank held Innovator US Equity Ultra Buffer ETF October as of Q4 2020.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.